aod9604 clinical trials results A completed AOD-9604 trial is not automatically a positive AOD-9604 result. FDA PCAC materials describe OPTIONS as a double-blind, randomized, placebo-controlled study in 502 adults with obesity. The briefing states that the Lean Stack (AOD-9604/MOTs-C/Tesamorelin/Ipamorelin) Compounded Injections Net Weight:5mg
aod9604 clinical trials resultsPay in 4 interest-free payments of $6.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1